Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | IMAC Holdings Inc expected to post a loss of 44 cents a share - Earnings Preview | 1 | Reuters | ||
23.10. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
26.09. | IMAC Holdings welcomes Jeffrey Busch to its Board of Directors | 2 | Investing.com | ||
25.09. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
23.09. | Imac Holdings stock hits 52-week low at $1.2 amid market challenges | 1 | Investing.com | ||
19.09. | IMAC Holdings, Inc.: IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology | 1 | GlobeNewswire (USA) | ||
13.09. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
23.08. | IMAC Holdings receives notification of deficiency from Nasdaq | 1 | Seeking Alpha | ||
23.08. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
23.08. | IMAC Holdings, Inc.: IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q | 319 | GlobeNewswire (Europe) | FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing... ► Artikel lesen | |
02.08. | IMAC Holdings Inc expected to post a loss of 44 cents a share - Earnings Preview | 2 | Reuters | ||
30.07. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
18.07. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
11.07. | IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors | 1 | GlobeNewswire (USA) | ||
02.07. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
18.06. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
14.06. | IMAC Holdings files to sell common stock and warrants, size not disclosed | 2 | Seeking Alpha | ||
13.06. | IMAC Holdings, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
24.05. | IMAC Holdings appoints Faith Zaslavsky as CEO | 2 | Seeking Alpha | ||
24.05. | IMAC Holdings, Inc.: IMAC Holdings Announces Leadership Succession | 1 | GlobeNewswire (USA) |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PLUS THERAPEUTICS | 1,204 | -2,27 % | Plus Therapeutics granted extension by Nasdaq | ||
ASENSUS SURGICAL | 0,305 | 0,00 % | KARL STORZ akquiriert den US-amerikanischen Robotik-Spezialisten Asensus Surgical | Tuttlingen / Research Triangle Park, USA (ots) - Das familiengeführte und international agierende Medizintechnikunternehmen KARL STORZ gibt die Akquisition des innovativen Robotik-Spezialisten Asensus... ► Artikel lesen | |
MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve president, CEO Preiner resigns | ||
LIFEWARD | 2,410 | +7,11 % | Lifeward, Inc.: Lifeward Launches Direct Sales of AlterG Product Line in Germany | MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing... ► Artikel lesen | |
EKSO BIONICS | 0,866 | +3,10 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Announces Third Quarter 2024 Financial Results | SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today... ► Artikel lesen | |
IMUNON | 0,865 | +0,58 % | Imunon, Inc.: IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting | ||
AVINGER | 0,771 | 0,00 % | Avinger, Inc.: Avinger to Announce Third Quarter 2024 Results on November 7, 2024 | REDWOOD CITY, CA / ACCESSWIRE / October 29, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system... ► Artikel lesen | |
ROCKWELL MEDICAL | 3,632 | +3,95 % | RMTI Stock Rises 138% in Q3: What Should You Do Ahead of Earnings? | ||
VIRIDIAN THERAPEUTICS | 20,600 | 0,00 % | Needham maintains buy on VRDN shares, cites recent clinical trial results | ||
SINTX TECHNOLOGIES | 3,040 | -0,33 % | Sintx Technologies, Inc. - 8-K, Current Report | ||
AETHLON MEDICAL | 0,356 | +1,71 % | Aethlon Medical, Inc.: Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update | Received Two Australian Ethics Committee Approvals for a Safety, Feasibility, and Dose Finding Study of Aethlon's Hemopurifier® in Patients with Solid Tumors Not Responding to Anti-PD-1 Antibodies... ► Artikel lesen | |
STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order | TORONTO, ON / ACCESSWIRE / July 9, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene... ► Artikel lesen | |
NEURONETICS | 1,028 | 0,00 % | Neuronetics extends Madryn registration rights period | ||
ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc.: Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall) | ||
HVIVO | 0,350 | +8,02 % | hVIVO PLC - Long Term Incentive Plan/ PDMR Notification |